Scribe Therapeutics Inc. (SCTX)
NASDAQ: SCTX · Real-Time Price · USD
30.25
-1.09 (-3.48%)
Sep 9, 2026, 11:39 AM EDT - Market open
Scribe Therapeutics Employees
Scribe Therapeutics had 89 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
89
Change
n/a
Growth
n/a
Revenue / Employee
$374,180
Profits / Employee
-$362,966
Market Cap
572.68M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 89 | 0 | - |
| Dec 31, 2025 | 89 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Autolus Therapeutics | 754 |
| REGENXBIO | 371 |
| Arvinas | 246 |
| ProKidney | 231 |
| Cabaletta Bio | 158 |
| Prime Medicine | 146 |
| OmniAb | 89 |
| Tectonic Therapeutic | 60 |
SCTX News
- 6 days ago - Scribe Therapeutics reports Q2 EPS ($2.62), consensus ($3.72) - TheFly
- 6 days ago - Scribe Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewsWire
- 6 days ago - Scribe Therapeutics Earnings release: Q2 2026 - Filings
- 6 days ago - Scribe Therapeutics Quarterly report: Q2 2026 - Filings
- 7 days ago - Scribe Therapeutics Slides: Investor presentation - Filings
- 8 days ago - Scribe Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 9 days ago - Scribe Therapeutics initiated with a Buy at H.C. Wainwright - TheFly
- 21 days ago - Leerink starts Scribe Therapeutics at Outperform on X-editor platform - TheFly